LPTX: Leap Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 79.12
Enterprise Value ($M) -1.62
Book Value ($M) 72.01
Book Value / Share 2.82
Price / Book 1.10
NCAV ($M) 70.72
NCAV / Share 2.77
Price / NCAV 1.12

Profitability (mra)
Return on Invested Capital (ROIC) -1.12
Return on Assets (ROA) -1.15
Return on Equity (ROE) -1.38

Liquidity (mrq)
Quick Ratio 7.41
Current Ratio 7.41

Balance Sheet (mrq) ($M)
Current Assets 81.76
Assets 83.05
Liabilities 11.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
8 days ago 13G/A Perceptive Advisors Llc 4.00 -84.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-21 22,644 134,290 16.86
2024-02-20 21,816 95,803 22.77
2024-02-16 73,185 302,004 24.23

(click for more detail)

Similar Companies
LIPO – Lipella Pharmaceuticals Inc. LIXT – Lixte Biotechnology Holdings, Inc.
LPCN – Lipocine Inc. LQDA – Liquidia Corporation
LSDI – Lucy Scientific Discovery Inc.


Financial data and stock pages provided by
Fintel.io